FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S. - FDA approves first medication for obstructive sleep apnea, which also promotes weight loss - FDA says the Zepbound shortage is over. Here's what that means for compounding pharmacies, patients who used off-brand versions - FDA approves weight loss drug Zepbound to treat obstructive sleep apnea - FDA approves weight loss drug Zepbound for sleep apnea - The FDA restricts a psychoactive mushroom used in some edibles - The FDA just approved Eli Lilly's Zepbound for sleep apnea -- and Medicare coverage could be next - FDA approves weight loss drug Zepbound for sleep apnea - FDA restricts psychoactive mushroom used in some edibles - FDA approves weight-loss drug to treat sleep apnea